Research Project

Project Title:	aHUS REGISTRY
Project Type:	Registry
Disease group(s):	Thrombotic microangiopathies
Project Summary:	The study will capture post-marketing safety data on patients treated with eculizumab or ravulizumab. Additionally, the study will collect information on the progression of disease in all patients.
Lead principal investigator(s):	Franz Schaefer, Heidelberg
Co-investigator(s):	Gema Ariceta, Barcelona
Project Period:	01/2012 - 12/2060
Sponsors:	Industry
ClinicalTrials.gov:	NCT01522183